Braden Michael Leonard is of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 102,076 shares of RPHM, which is worth approximately $171,487. The most recent transaction as insider was on Oct 07, 2024, when has been sold 102,076 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K
n/a 3M change
n/a 12M change
Total Value Held $171,487

Braden Michael Leonard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2024
BUY
Other acquisition or disposition
-
102,076 Added 50.0%
102,076 Common Stock

Also insider at

GMTX
Gemini Therapeutics, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
RVP
RETRACTABLE TECHNOLOGIES INC Healthcare
ASTC
ASTROTECH Corp Industrials
MTCR
Metacrine, Inc. Healthcare
STSA
Satsuma Pharmaceuticals, Inc. Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
AVRO
AVROBIO, Inc. Healthcare
ACRS
Aclaris Therapeutics, Inc. Healthcare
ADVM
Adverum Biotechnologies, Inc. Healthcare
ANTX
AN2 Therapeutics, Inc. Healthcare
TLIS
Talis Biomedical Corp Healthcare
BML

Braden Michael Leonard

Zionsville, IN

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Track Activities on RPHM